Name | Last modified | Size | Description | |
---|---|---|---|---|
Parent Directory | - | |||
1-1-1-BPharmRevisedO..> | 2022-07-05 19:19 | 1.4M | ||
1-1-3.pdf | 2022-07-05 19:19 | 12M | ||
1-4-1.pdf | 2022-07-05 19:19 | 3.6M | ||
1-4-2-Stakeholders-f..> | 2022-07-05 19:19 | 1.7M | ||
2-2.pdf | 2022-07-05 19:19 | 529K | ||
3-3-2.pdf | 2022-07-05 19:19 | 16M | ||
3-3-3.pdf | 2022-07-05 19:19 | 7.0M | ||
3-4-3-3-4-4-Attendan..> | 2022-07-05 19:19 | 12M | ||
3-4-3-3-4-4-NSS-Repo..> | 2022-07-05 19:19 | 14M | ||
3.2-IQAC-AQAR-2020-2..> | 2022-08-17 07:19 | 502K | ||
6-2-2-Organization-H..> | 2022-08-01 11:30 | 181K | ||
6.2.2 Organization H..> | 2022-08-01 11:29 | 181K | ||
7-1-1.pdf | 2022-07-05 19:19 | 42M | ||
7-1-2.pdf | 2022-07-05 19:19 | 2.8M | ||
7-1-5.pdf | 2022-07-05 19:19 | 8.4M | ||
7-1-6.pdf | 2022-07-05 19:19 | 8.7M | ||
7-1-7.pdf | 2022-07-05 19:19 | 37M | ||
7-1-8.pdf | 2022-07-05 19:19 | 6.1M | ||
7-1-9.pdf | 2022-07-05 19:19 | 21M | ||
7-2-1-best-practice.pdf | 2022-07-05 19:19 | 219K | ||
IQAC-meeting-complia..> | 2022-07-05 19:19 | 4.4M | ||